“Either way, you cant find this kind of opportunity as a pharma investment trading at a 2 million valuation; hell you cant find it trading at 20 mil valuation.”
Bingo. Very few realize how rare this is to find a small bio with this much in the pipeline and this far along on progress at this low of a market cap. The room for the pps to move up based on a reasonable market cap valuation over the next year is incredible to think about.
News 
Market Data 
Discover 
AI
